$CCEP

Coca-Cola Europacific Partners PLC (AMS:CCEP) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Coca-Cola Europacific Partners (AMS:CCEP) reported half-year results, with revenues of €11b and statutory EPS of €4.26, both in line with analyst estimates, according to the article. For 2026, analysts forecast revenues of €21.6b and EPS of €4.37, unchanged from prior models. The consensus price target remains €95.14, with a range of €80.48 to €112.

Original reporting
Published Aug 7, 2026, 6:28 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:20 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CCEP
Neutral
medium confidence
Mentioned
$CCEP
Relevance
4/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$CCEPNeutralLow
01

Why it matters

Analysts are portrayed as reconfirming 2026 revenue and EPS expectations, with no change to the consensus price target, while the forecast growth rate is described as slowing versus history and the industry.

02

Market read

For traders, the key takeaway is lack of new consensus revisions after the half-year print, but the growth slowdown forecast may still matter for longer-horizon positioning.

03

What to watch

The piece does not detail margin, volume, pricing, FX, or guidance drivers; traders may need to verify whether the “in line” characterization masks offsetting positives and negatives.

Relevance 4/10Novelty 3/10Timing: post half-year earnings recap and analyst-forecast check

Background

Simply Wall St summarizes CCEP’s half-year results and compares current analyst forecasts versus those modeled before the report.

Company-level read

Ticker impact

$CCEPNeutralMedium confidence
Context

CCEP’s half-year results are described as in line with estimates, with 2026 revenue and EPS forecasts unchanged and a €95.14 price target reiterated.

Expected impact

Near-term reaction risk is low; any move is more likely tied to broader market sentiment than new CCEP-specific information.

Evidence & confidence

The newest concrete facts are that revenues and EPS were in line and that consensus forecasts and the €95.14 target did not change, which typically reduces the probability of a fresh repricing.

Market effects

Suggests muted near-term growth expectations for a large bottler, with revenue growth forecast to slow versus both its own history and the wider industry.

Primarily impacts European consumer staples sentiment tied to beverage bottlers.

Limited spillover beyond global packaged beverage/bottling peers, since the article emphasizes no major estimate changes.

Counterpoint

Even with “in-line” earnings, the forecast implies slower revenue growth than both CCEP’s past and the industry, which can still pressure valuation multiples.

Key entities

  • Coca-Cola Europacific Partners PLC

    Subject of the article; half-year results are described as in line and analyst forecasts are said to be unchanged.

Related articles

$CCEPMed

Coca-Cola Europacific Partners PLC Q2 2026 Earnings Call Summary

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results driven by volume growth and positive revenue per case, with Zero Sugar, Energy and Sports outperforming. Management cited FIFA World Cup activations, margin expansion of 30 bps, and reaffirmed full-year 2026 guidance despite 6 fewer trading days. Capex includes a Manila greenfield site in 2027 and cooler placements.

$CCEPMedAI 8/10

Revenue Tops €10.7bn In Coca-Cola Europacific Partners’ H1

Coca-Cola Europacific Partners (CCEP) reported H1 2026 revenue of €10.7bn, up 4.4% reported and 6.1% FX neutral. Operating profit was €1.46bn reported (+6.9%) and profit after tax €991m (+5.8%). Total volume rose to 2,041m unit cases (+5.6%). Full-year guidance calls for ~3-4% revenue and ~7% operating profit growth.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported first-half 2026 results on an earnings call. Revenue rose 6.1% to EUR 10.7B, operating profit increased 8.1% to EUR 1.5B, and diluted EPS rose 10.6% to EUR 2.20. Free cash flow was EUR 435M, with full-year guidance reaffirmed and EUR 600M of a EUR 1B buyback completed.

$CCEPMed

Coca-Cola Europacific shares lose fizz after interim results

Coca-Cola Europacific Partners reported higher first-half profit and reaffirmed 2026 guidance, but shares fell 4.3% to 7,710p after interim results. Revenue rose 4.4% to €10.7bn, operating profit increased 6.9% to €1.5bn, and diluted EPS grew 9.1% to €2.17. Guidance: currency-neutral revenue growth 3% to 4%, operating profit growth around 7%, free cash flow at least €1.7bn.

$CCEPMedAI 8/10

Coca-Cola Europacific Partners plc Announces Results for The Six Months Ended 3 July 2026

Coca-Cola Europacific Partners (CCEP) reported results for the six months ended 3 July 2026. Days-adjusted group volume rose 2.2% (Europe +1.6%, APS +3.5%). H1 revenue was +4.4% reported, comparable operating profit €1,481m (+8.1%), comparable diluted EPS €2.20 (+10.6%), and free cash flow €435m. Interim dividend was €0.82. FY26 guidance was reaffirmed.